The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between compartments and elimination determines the rate of change in drug concentration. The transfer constants k12 and k21 depict the rate at which the drug moves between these compartments.
The method of residuals is employed to estimate these transfer constants and other pharmacokinetic parameters. In this method, the slope of the residual line provides the elimination rate constant (k). From k, we can calculate the elimination half-life (t1/2). Other essential pharmacokinetic parameters like the volume of distribution (Vd) and clearance (Cl) can also be determined using suitable equations. All these parameters help in understanding the behavior of the drug within the body.
The two-compartment model for intravenous bolus administration comprises central and peripheral compartments, representing the distribution of a drug in the body.
First-order distribution rate or transfer constants like k12 and k21 denote the reversible drug transfer rate between compartments.
The hybrid first-order constants for the rapid distribution and slow elimination depend on k12, k21, and the elimination rate constant from the central compartment k10 .
The plasma concentration-time profile post-IV bolus administration follows a biexponential curve, indicating distribution and elimination phases.
The method of residuals can resolve the biexponential distribution curve into individual exponents. The slope of the residual line obtained from the semilog plot of plasma drug concentration values versus time yields the transfer constants.
The elimination half-life is calculable from the elimination rate constant for the entire body β.
Other pharmacokinetic parameters, such as volume of distribution and clearance, can be determined.